Collins Helen Louise
5 of 19 shown
The 5 most recent of 19 visible filings, newest first.
- Enliven Therapeutics, Inc. Chief medical officer5,000 sharesOption exercise
- Enliven Therapeutics, Inc. Chief medical officer$192,342Open-market sale
- Enliven Therapeutics, Inc. Chief medical officer$12,400Option exercise
- Enliven Therapeutics, Inc. Chief medical officer5,000 sharesOption exercise
- Enliven Therapeutics, Inc. Chief medical officer$12,356Open-market sale